Reklāma
Forex ziņas
Dollar Extends Gains Amidst Debt Drama
Despite all the noise surrounding the U.S. debt limit and the negotiations to avert a default, the Dollar extended gains during the week ended May 26.
RTTNews |
820 days ago
Spain Inflation Eases Unexpectedly To Lowest In 22 Months
Spain's consumer price inflation eased unexpectedly in May to the lowest level in nearly two years, mainly due to a fall in fuel prices, flash estimates from the statistical office INE showed Tuesday. The consumer price index, or CPI, climbed at a slower pace of 3.2 percent year-over-year in May after a 4.1 percent increase in April.
RTTNews
|
820 days ago
U.S. Dollar Trades Lower Against Majors
The U.S. dollar was lower against its major counterparts in the European session on Tuesday.
RTTNews
|
820 days ago
U.S. Consumer Confidence Edges Modestly Lower In May
Consumer confidence in the U.S. saw a modest decrease from an upwardly revised level in the month of May, according to a report released by the Conference Board on Tuesday. The Conference Board said its consumer confidence index edged down to 102.3 in May from an upwardly revised 103.7 in April.
RTTNews
|
820 days ago
Electrolux To Set Provision Of About SEK 650 Mln To Settle French Antitrust Case
Swedish home appliance major Electrolux AB (ELUXY.PK) announced Tuesday that it will set a provision of approximately SEK 650 million in connection to the previously reported investigation of alleged breaches of antitrust rules in France between 2009 and 2014.
RTTNews
|
820 days ago
Pound Higher As Risk Sentiment Improves
The pound firmed against its major counterparts in the European session on Tuesday, as the U.S. debt ceiling deal readies for vote.
RTTNews
|
820 days ago
BioLight Inks Agreement With Alexion To Explore Technology For Diagnosis Of Retinal Diseases
BioLight Life Sciences Ltd. announced Tuesday it has signed a research collaboration agreement with Alexion Pharmaceuticals, Inc. (ALXN), a subsidiary of AstraZeneca plc (AZN, AZN.L), focusing on exploring a groundbreaking technology that utilizes natural tears for the potential diagnosis of retinal diseases.
RTTNews
|
820 days ago
more news
Weak Bank Lending Damps Eurozone Growth Prospects
Eurozone bank lending growth weakened further in April reflecting the transmission of the European Central Bank's tight monetary policy and signaled weak economic growth.
Data published by the ECB on Tuesday showed that credit to euro area residents grew at a slower pace of 1.5 percent in April from a year ago, while credit to general government dropped 0.9 percent.
RTTNews
|
820 days ago
Canadian Shares Likely To Open On Mixed Note
Bay Street is likely to see a mixed start on Tuesday with investors tracking updates on U.S. debt ceiling deal, and reacting to the trend in commodities markets.
RTTNews
|
820 days ago
Atea Pharma Rejects Unsolicited Proposal From Tang Capital Partners
Biopharmaceutical company Atea Pharmaceuticals, Inc. (AVIR) announced Tuesday that its Board of Directors unanimously rejected the unsolicited proposal from Tang Capital Partners, LP on behalf of Concentra Biosciences, LLC to acquire all outstanding common shares of Atea for $5.75 per share in cash, plus a contingent value right representing the right to receive 80% of the net proceeds payable from any license or disposition of Atea's programs.
RTTNews
|
820 days ago
Magnachip To Spin-off Display And Power Businesses Into Separate Entities
Magnachip Semiconductor Corp. (MX) announced Tuesday that the Company is separating its display and power businesses into separate entities, following approval by its board of directors and strategic review committee.
RTTNews
|
820 days ago
Eurozone Economic Confidence Hits 6-Month Low
Adding to concerns over growth prospects, euro area economic sentiment deteriorated to the lowest in six months in May reflecting lower confidence in industry, services and retail trade. The economic sentiment index fell to 96.5 from 99.0 in April, survey results from the European Commission showed Tuesday. This was the lowest reading since November and also below economists' forecast of 98.9.
RTTNews
|
820 days ago
Pfizer Says Pivotal Phase 3 BASIS Clinical Trial Of Marstacimab Met Primary Endpoints
Drug major Pfizer Inc. (PFE) announced Tuesday that the pivotal Phase 3 BASIS clinical trial (NCT03938792) evaluating marstacimab has met its primary endpoints, having demonstrated statically significant and clinically meaningful effects.
RTTNews
|
820 days ago
Stay up to date!
Add Ziņas to your browser
Add To Chrome
